Document is current
Any future updates will be listed below
-
Authors
Cortés-Vicente, Elena
Guerrero, Antonio
Díaz, Carmina
Martínez, Eva
Toja-Camba, Francisco J.
Abad, María R.
Serra, José M.
Trillo, Jose L.
Martín Machín, Celia
Gil, Alicia
-
Funding
Funding for this research was provided by:
Argenx
- License Information
-
More Information
Article History
Received: 24 October 2025
Accepted: 2 January 2026
First Online: 27 January 2026
Declarations
:
: María R. Abad: I declare that I have received honoraria for the development of this project from argenx and speakers’ fees from UCB Pharma, Johnson & Johnson, Vertex, Organon, Biogen, CINFA, Astra Zeneca, GSK, and Sanofi Aventis. Elena Cortés-Vicente: I declare that I have received honoraria for speaking engagements and consultancy activities from argenx, UCB, Alexion, and Janssen. Francisco J. Toja-Camba: I declare that I have received honoraria for the development of this project from argenx. Carmina Díaz: I declare that I have received honoraria for the development of this project from argenx. Included received speakers fees from ALEXION and UCB. Eva Martínez: I declare that I have received honoraria for the development of this project from argenx. José M. Serra: I declare that I have received honoraria for the development of this project from argenx. Jose L. Trillo: I declare that I have received honoraria for the development of this project from argenx.
: The authors declare that no experiments on humans or animals have been carried out for this research. The authors declare that no patient data appear in this article. Full consent to participate in the study and to publish the findings was obtained from all contributors.
